BioUtah president & CEO Kelvyn Cullimore interviews Mayer Brown’s George O’Brien to discuss legal issues life sciences companies face when dealing with the FDA.
Skip to main content
Insights特集
- Banking & Finance
- Capital Markets
- Corporate & Securities
- Cybersecurity & Data Privacy
- Financial Services
- Global Investigations & White Collar Defense
- Lending
- Litigation & Dispute Resolution
- Mergers & Acquisitions
- Private Credit
Insights特集
BioUtah president & CEO Kelvyn Cullimore interviews Mayer Brown’s George O’Brien to discuss legal issues life sciences companies face when dealing with the FDA.
